PGGM Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,937
| Closed | -$1.85M | – | 366 |
|
|
2024
Q2 | $1.85M | Sell |
3,937
-2,354
| -37% | -$1.1M | 0.03% | 260 |
|
|
2024
Q1 | $2.63M | Sell |
6,291
-122
| -2% | -$51K | 0.04% | 248 |
|
|
2023
Q4 | $2.61M | Buy |
6,413
+3,018
| +89% | +$1.23M | 0.04% | 252 |
|
|
2023
Q3 | $1.18M | Buy |
3,395
+2,183
| +180% | +$759K | 0.02% | 294 |
|
|
2023
Q2 | $427K | Buy |
+1,212
| New | +$427K | 0.01% | 335 |
|
|
2023
Q1 | – | Sell |
-7,896
| Closed | -$2.28M | – | 405 |
|
|
2022
Q4 | $2.28M | Sell |
7,896
-3,200
| -29% | -$924K | 0.04% | 276 |
|
|
2022
Q3 | $3.21M | Buy |
+11,096
| New | +$3.21M | 0.06% | 250 |
|
|
2021
Q3 | – | Sell |
-963
| Closed | -$194K | – | 437 |
|
|
2021
Q2 | $194K | Buy |
+963
| New | +$194K | ﹤0.01% | 388 |
|
|
2020
Q4 | – | Sell |
-274,529
| Closed | -$74.7M | – | 361 |
|
|
2020
Q3 | $74.7M | Buy |
274,529
+109,698
| +67% | +$29.9M | 0.39% | 65 |
|
|
2020
Q2 | $47.9M | Buy |
+164,831
| New | +$47.9M | 0.28% | 87 |
|